Literature DB >> 17722673

Dialysis access thrombosis in a family cohort.

Arash Bornak1, Lee Kirksey.   

Abstract

In 2004, 464,952 individuals were newly diagnosed with chronic renal insufficiency (CRI); 102,356 of those newly diagnosed patients required initiation of dialysis for end-stage renal disease (ESRD). Among the ESRD population, about one third is African American despite the fact that this population represent only about 12% of the total population in the United States (U.S. Renal Data System 2006). Familial aggregation of kidney disease disproportionately affects minorities. This paper describes the detection and management of dialysis access failure due to hypercoagulable states in a genetically related group. We also discuss the implications that associated familial disorders may have on the diagnoses, treatment and survival for this devastating illness.

Entities:  

Mesh:

Year:  2007        PMID: 17722673      PMCID: PMC2574299     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  18 in total

1.  Hypercoagulopathy in a hemodialysis patient: are elevations in factors VII and VIII effective?

Authors:  E Baskin; O Duman; N Beşbaş; S Ozen
Journal:  Nephron       Date:  1999       Impact factor: 2.847

2.  Stenosis surveillance of hemodialysis grafts by duplex ultrasound reduces hospitalizations and cost of care.

Authors:  Neville R Dossabhoy; Sunanda J Ram; Raja Nassar; Jack Work; J Mark Eason; William D Paulson
Journal:  Semin Dial       Date:  2005 Nov-Dec       Impact factor: 3.455

Review 3.  Routine surveillance in vascular access for hemodialysis.

Authors:  Mitchell L Henry
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-08-24       Impact factor: 7.069

4.  Thrombophilia and the risk for hemodialysis vascular access thrombosis.

Authors:  Greg A Knoll; Philip S Wells; Darlene Young; Sherry L Perkins; Rachel M Pilkey; Jennifer J Clinch; Marc A Rodger
Journal:  J Am Soc Nephrol       Date:  2005-02-23       Impact factor: 10.121

5.  Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.

Authors:  Jay L Xue; Jennie Z Ma; Thomas A Louis; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2001-12       Impact factor: 10.121

6.  Inflow stenosis in arteriovenous fistulas and grafts: a multicenter, prospective study.

Authors:  Arif Asif; Florin N Gadalean; Donna Merrill; Gautam Cherla; Cristian D Cipleu; David L Epstein; David Roth
Journal:  Kidney Int       Date:  2005-05       Impact factor: 10.612

7.  Family history of end-stage renal disease among incident dialysis patients.

Authors:  B I Freedman; J M Soucie; W M McClellan
Journal:  J Am Soc Nephrol       Date:  1997-12       Impact factor: 10.121

8.  Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access.

Authors:  C J LeSar; H W Merrick; M R Smith
Journal:  J Am Coll Surg       Date:  1999-07       Impact factor: 6.113

9.  Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis.

Authors:  R Prakash; C C Miller; W N Suki
Journal:  Am J Kidney Dis       Date:  1995-08       Impact factor: 8.860

10.  Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group.

Authors:  S D Fihn; M McDonell; D Martin; J Henikoff; D Vermes; D Kent; R H White
Journal:  Ann Intern Med       Date:  1993-04-01       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.